Venture • Life Science

GIMV Invests In Eurocept

On May 12, 2013, private equity firm GIMV invested in life science company Eurocept

Investment Context

This is GIMV’s 10th transaction in the Life Science sector.
This is GIMV’s 23rd transaction in the Netherlands.

Investment Fate

Eurocept was sold to management in 2022.

Explore All 557 Venture Life Science Deals - Search the Database Free

Investment Summary
Date	May 12, 2013
Target	Eurocept
Sector	Life Science
Investor(s)	GIMV
Deal Type	Venture

Target Company

Eurocept

Houten, Netherlands

Eurocept is a healthcare company offering a unique combination of specialty pharma and medical homecare. Eurocept Pharmaceuticals is responsible for the registration, marketing, distribution and sale of speciality medicines in the fields of anesthetics, psychiatry, urology, pediatrics and infectious diseases. Eurocept Homecare provides medical specialist homecare and related out-patient medical technology for medicine and food administration. Eurocept was founded in 2001 and is based in Houten, Netherlands.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

GIMV

Antwerp, Belgium

Investor Investor

Category	Private Equity Firm
Founded	1980
PE ASSETS	2.0B EUR
Size	Large
Type	Sector Agnostic

DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.

Deal Context for Investor	#
Overall	78 of 170
Sector: Life Science	10 of 24
Type: Venture	24 of 39
Country: Netherlands	23 of 42
Year: 2013	4 of 10

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2013-02-01	Lintor/Verbinnen Olen, Belgium Lintor-Verbinnen is a chicken processor in Belgium. The group consists of a chicken slaughterhouse (Lintor) and a processor and packer of a wide range of fresh chicken products (Verbinnen). The company is unique in being vertically integrated, with slaughtering, preparation, packaging as well as processing of the slaughter waste on a single site. Lintor/Verbinnen was founded in 1958 and is based in Olen, Belgium.	Sell	-

DATE

TARGET

DEAL TYPE

VALUE

2013-02-01

Lintor/Verbinnen

Olen, Belgium

Lintor-Verbinnen is a chicken processor in Belgium. The group consists of a chicken slaughterhouse (Lintor) and a processor and packer of a wide range of fresh chicken products (Verbinnen). The company is unique in being vertically integrated, with slaughtering, preparation, packaging as well as processing of the slaughter waste on a single site. Lintor/Verbinnen was founded in 1958 and is based in Olen, Belgium.

Sell

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2013-06-14	Lampiris SA Liège, Belgium Lampiris SA is a provider of gas and green electricity to private, corporate and public sector customers. It holds a market share of 9% of the gas market and 6.5% of the electricity market, making it Belgium's third largest energy provider.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2013-06-14

Lampiris SA

Liège, Belgium

Lampiris SA is a provider of gas and green electricity to private, corporate and public sector customers. It holds a market share of 9% of the gas market and 6.5% of the electricity market, making it Belgium's third largest energy provider.

Buy

Explore Related M&A Activity

Life Science M&A - Venture M&A Deals - Netherlands M&A - 2013 M&A